ETFs that hold Bridgebio Pharma Inc
28 US listed ETFs hold Bridgebio Pharma Inc. HELX holds the most, at 3.54% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| HELX | Franklin Genomic Advancements ETF | 3.54% | Jun 30, 2026 |
| CANC | Tema Oncology ETF | 2.39% | Sep 18, 2026 |
| BBP | Virtus Biotech ETF | 1.52% | Apr 30, 2026 |
| LFSC | F/m Emerald Life Sciences Innovation ETF | 1.17% | May 31, 2026 |
| XBI | State Street SPDR S&P Biotech ETF | 0.96% | Sep 17, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.87% | Sep 19, 2026 |
| ILDR | First Trust Innovation Leaders ETF | 0.83% | Sep 18, 2026 |
| IBB | iShares Biotechnology ETF | 0.82% | Sep 17, 2026 |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.74% | May 31, 2026 |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.66% | Sep 19, 2026 |
| WDNA | WisdomTree BioRevolution Fund | 0.48% | Jun 30, 2026 |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.39% | Aug 31, 2026 |
| ITWO | ProShares Russell 2000 High Income ETF | 0.31% | May 31, 2026 |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.30% | Jan 31, 2026 |
| VB | Vanguard Morningstar Small-Cap ETF | 0.17% | Aug 31, 2026 |
| VHT | Vanguard Health Care ETF | 0.16% | Aug 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.16% | Aug 31, 2026 |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.09% | Jun 30, 2026 |
| XT | iShares Future Exponential Technologies ETF | 0.06% | Sep 17, 2026 |
| VONG | Vanguard Russell 1000 Growth ETF | 0.04% | Aug 31, 2026 |
| IWF | iShares Russell 1000 Growth ETF | 0.03% | Sep 17, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.03% | May 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% | Sep 17, 2026 |
| IWB | iShares Russell 1000 ETF | 0.02% | Sep 17, 2026 |
| VTI | Vanguard Morningstar Total Stock Market ETF | 0.02% | Aug 31, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.02% | Jun 30, 2026 |
| DFUS | Dimensional U.S. Equity Market ETF | 0.01% | Apr 30, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.01% | Aug 31, 2026 |
What this counts
Bridgebio Pharma Inc (ticker BBIO) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding Bridgebio Pharma Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/bbio/ Free to use with attribution; the underlying files are at Open data.